Moderna stock on track for 20% weekly gain after US bird flu death
Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in ...
STAT43m
Pharmalittle: We’re reading about FDA commish’s parting thoughts, a warning on RSV shots, and more
He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...
Abzena Strengthens Board With Appointment Of Biopharma Industry Leader, Dr Moncef Slaoui
Dr Moncef Slaoui currently serves as an advisor to Medicxi and is on the Board of Directors of several companies including Cedar Health, Arcturus Therapeutics, Altesa, Zephyr AI and Vicebio. He has ...
MedPage Today24m
FDA Adds Guillain-Barre Syndrome Warning to Two RSV Vaccines
The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...